Amryt Pharma Share Discussion Threads

[bigwavedave] 07/7/2016 12:45

AGM day and another slip in the share price Must be at an all time low now.

[papillon] 06/7/2016 15:23

Presentation looks good. Could have a big multi-bagger on our hands by the end of 2018.

[jacksonpollack] 05/7/2016 15:27

Good interview. So where is all the revenue going from the sale of product in Germany? £1m a year is not to be sniffed at. If Amyt own the company then they should own the £1m a year revenue too.

[timbo003] 05/7/2016 12:24

There's a new video presentation (now available on youtube) given by Rory Nealon (CFO) at the Biotech Conference on June 17th. I attended the conference and was quite impressed I'm tempted to buy a few when I've got a bit more spare cash available early next month.

Note the insightful questions from one of the attendees in the front row ☺

[jacksonpollack] 05/7/2016 12:17

Boring zzzzzzzzzzzzzz

[papillon] 01/7/2016 17:16

Most AIM BoD's are peddling a dream; a fantasy. The vast majority of these dreams/fantasises fail to come true.

Most PI's who invest in AIM shares buy into that dream/fantasy. The vast majority lose most, if not all, of the money they invested. The BoD's rarely, if ever, lose money because they receive big salaries/fees often for little, or even very little, work. Many have very little exposure to companies shares; those that do have a large exposure got their shares for little, or no, money before the company floated.

Rarely is an AIM company successful (even very successful) and make their long term shareholders very rich. ASOS is an example.

Will AMYT make the likes of Jacksonpollack plenty of money? Who knows? It depends on what news the company issues over the next few years; whether it's good or bad news. Good news is never guaranteed with an oil explorer, or biotech. Bad news is more than likely.

I'm continuing to hold my small holding of AMYT shares. The BoD have a dream/fantasy. That means I'm buying into that dream/fantasy and hoping I make some money by doing so.

I expect that the AMYT share price will have multi-bagged by the time we get to the announcement of phase III trial results. Good results could see the AMYT share price multi-bag yet again; bad news is not worth thinking about!!

[jacksonpollack] 01/7/2016 16:18

Hell is too good for most bod's on AIM.

[currypasty] 01/7/2016 14:54

why don't you go and give em hell ?

[bigwavedave] 01/7/2016 12:28

AGM next Thursday. Anyone going?

[pottermagic2310] 01/7/2016 10:56

I think we should sit this out until Spring 2017, top-up as occasional lows provide an opportunity and hope we see some well-received Products flourish in target Markets.

[jacksonpollack] 01/7/2016 08:41

Surely one of the wage packets on the bod can come up with an idea to generate money for the company and its shareholders rather than just take money out.

Episalvan® is a prescription pharmaceutical product which accelerates wound healing. It’s approved in Europe for the treatment of partial-thickness wounds (PTWs) in adults. Such wounds are caused by, including burns, STSG donor sites, skin grafting and other dermatological procedures, aesthetic procedures, decubitus (stage II), toxic epidermal necrolysis and radiation and drug side effects.

Episalvan® is a topical product which is simply formulated to contain two ingredients, its betulin-based active ingredient and sunflower oil as the only excipient. The absence of further ingredients potentially reduces the likelihood of skin irritation. Episalvan® gel provides a protective cover to the wound and prevents dressings from sticking to the wound, further supporting its pharmacological action to accelerate wound healing.

The Imlan® products’ regenerative and anti-inflammatory properties have transformed skin care. Betulin is the active ingredient in the Imlan® products and also functions as the stabilizer of the creams and lotions. This eliminates the use of emulsifiers and preservatives that are usually found in skin care products and that are for many a cause of skin irritation. Imlan® is a 100-percent natural skin care line that contains no colorants, fragrances, paraffin or lanolin. Imlan® Creme Pur contains just three ingredients: Betulin, oil and water.

Please visit www.imlan.de/en.html for further information.

[papillon] 30/6/2016 16:22

I expect to see a bounce up from here in the short term. Maybe up towards 19p again. Now is not the time to sell; more like a time to have a small top up.

I expect AMYT to multi-bag from here in the longer term as we get nearer to the phase III results (early 2018?). This will result in a gradual readjustment upwards in the share price

Whether it will be worthwhile holding for the actual phase III results will depend on your assessment of risk.

[currypasty] 27/6/2016 09:32

why not put your comments directly too them ?

[jacksonpollack] 27/6/2016 09:13

FFS. Not another one on the payroll. Here's a thought, try making some
money for the shareholders instead of constantly plundering the funds

[divmad] 18/6/2016 22:35

I guess the only long term investor in Amryt is CF himself, with his old 4p purchases. I wonder if he shares JP's emotional outbursts?

[strangeman] 18/6/2016 22:23

... isn't the med full of sh1t too? ;-)

[buffythebuffoon] 18/6/2016 22:03

I guess we've got another bite of the cherry, and we'll see any upside from the sale of the O&G assets.

Having said that, he could have just returned the money to us, but chose to put it in another investment of his. Some would say it's a dodgy practice, searching and searching for somewhere better to put the cash, and after an exhaustive search, wouldn't you know it, it just happens to be a company he has an investment in.

It's all bollix, to borrow your spelling.

Still, I just have this feeling in my water it will come good. It doesn't happen very often and I've not got a urine infection, so things could be on the up before too long. 24 months will see you floating in the med.....

Buffy

[buffythebuffoon] 18/6/2016 11:34

Blimey JP, a long post!

Buffy